Skip to main content

Supernus Pharma selected Vistaar

Supernus Pharmaceuticals, Inc., a leading pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, has recently selected Vistaar, a leading provider of regulatory intelligence solutions. This collaboration aims to enhance Supernus Pharma’s global regulatory, clinical, and compliance capabilities.As a company committed to revolutionizing the healthcare industry, Supernus Pharma recognizes the critical importance of staying up-to-date with the ever-evolving regulatory landscape.


By leveraging Vistaar’s regulatory intelligence solutions, Supernus Pharma aims to ensure compliance with all regulatory requirements across various therapeutic areas.

Vistaar’s combination of robust technology and experienced global regulatory intelligence team makes it the ideal choice for companies seeking innovative solutions to navigate diversity of the regulatory landscape in BioPharma. The selection of Vistaar by Supernus further reinforces its position as competent provider of regulatory intelligence solutions.

Both Supernus Pharma and Vistaar are confident that this partnership will drive significant advancements in the pharmaceutical industry and foster innovation in drug development and regulatory compliance.